ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance

Ari Hashimoto(Hokkaido University), Hisataka Sabe(Hokkaido University)
Oncogenesis
September 12, 2016
Cited by 45


Related Papers